TMP920 - ≥99% , CAS No.1421837-45-7

CAS: 1421837-45-7 Cat. No.: T647858 Formule: C29H30N2O3 Poids moléculaire: 454.56
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ ≥99%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Taille
Allemagne (EU)
USA*
Prix
Qté
5mg
T647858-5mg
Sur commande · 8–12 semaines
330,52€
10mg
T647858-10mg
Sur commande · 8–12 semaines
564,81€
50mg
T647858-50mg
Sur commande · 8–12 semaines
1 684,19€
100mg
T647858-100mg
Sur commande · 8–12 semaines
2 864,32€
Enter a quantity for the sizes you want to add.

Vue d’ensemble

TMP920 is a highly potent and selective RORγt antagonist. TMP920 inhibits RORγt binding to the SRC1 peptide with an IC 50 of 0.03 μM

In Vitro

TMP920 (0.09-30 μM) starts to show toxic effects on cell growth at >10 μM in Naïve CD4 + T cells. TMP920 suppresses Th17 cell differentiation and lost its IL-17 inhibitory effect at <2.5 μM in vitro. TMP920 suppresses IL-17 production from differentiated Th17 cells in vitro. TMP920 suppresses the Th17 cell transcriptome and promotes alternate T-cell subsets. TMP920 significantly reduces RORγt-DNA interactions. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Cytotoxicity AssayCell Line: Naïve CD4 + T cells Concentration: 0.09-30 μM Incubation Time: 48 hours Result: Has toxic effects on cell growth at >10 μM.

Form:Solid

IC50& Target:IC50: 0.03 μM (RORγt)

Spécifications

Spécifications et pureté
≥99%
Mécanismes biochimiques et physiologiques
TMP920 is a highly potent and selective RORγt antagonist. TMP920 inhibits RORγt binding to the SRC1 peptide with an IC 50 of 0.03 μM.
Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Pureté
≥99%
Noms et identifiants
Poids moléculaire
454.56

Données avancées

Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propriétés chimiques et physiques
SolubilitéDMSO : 62.5 mg/mL (137.50 mM; Need ultrasonic)
Calculateurs de solution
Avis

Avis des clients

Application Protocols

While no item-specific, validated application protocols are provided, the following general procedures are widely used for small-molecule research compounds.

Preparation of DMSO stock solution (general):

  • Bring vial to room temperature in a desiccator. Weigh desired amount quickly. Add dry DMSO to prepare a concentrated stock (e.g., 10–50 mM depending on solubility). Vortex and sonicate briefly until dissolved. If particulate remains, warm gently (<40 °C) and re-sonicate.
  • Optional: Sterile-filter through 0.2 µm PTFE into low-bind tubes if sterility is required for cell assays. Record exact concentration and date.

Plate dispensing and dilution:

  • Use acoustic or pin-tool transfer for nL–µL volumes. Maintain consistent DMSO final concentration across wells (commonly 0.1–0.5% v/v) to avoid solvent bias.
  • For aqueous media, pre-dilute stock into intermediate DMSO:buffer mixes to prevent crash-out; inspect turbidity visually and by LC.

Stability checks:

  • Assess bench stability over the assay interval by re-injecting samples at end-of-run. Protect from light if chromophores are suspected; actual photosensitivity is not specified for this item.

Documentation:

  • Record lot number, storage conditions, and cumulative freeze–thaw cycles. Archive LC–MS/HPLC traces from the receiving CoA and pre-assay verification.

These procedures are general and should be adapted to your assay and compound-specific behavior.

Biological Roles

No biological mechanism-of-action or target information is provided for TMP920 in this product data. Without structural or pharmacological annotation, specific biological roles cannot be asserted for this item.

General guidance for research compounds:

  • If you possess literature associating CAS 1421837-45-7 or the name TMP920 with a biological target, verify equivalence of structure and lot identity before interpreting activity data.
  • Establish baseline activity in your own system via concentration–response testing and orthogonal assays; do not rely on assumed target engagement without confirmation.
  • Assess nonspecific liabilities (aggregation, redox cycling, fluorescence interference, metal chelation) using control assays if your screening paradigm is susceptible to artifacts.
  • Confirm stability in relevant media (buffer, serum-containing medium) and measure free fraction if binding to proteins or plastics is suspected.

Important: This product is supplied strictly for research use only; no clinical, diagnostic, or therapeutic claims are made or implied.

Buffer Applications

TMP920 is not presented as a buffering agent or pH modifier, and no pKa or ionic data are provided.

  • Not typically applicable: There is no basis to recommend specific buffer systems for buffering capacity.
  • Practical note: If TMP920 must be formulated in aqueous media for research assays, select buffers compatible with your biology (e.g., PBS, HEPES, Tris) and confirm compound solubility and stability at the chosen pH. Maintain minimal DMSO cosolvent where possible and validate that the buffer does not induce precipitation or chemical degradation.

For any buffer-related performance claims, determine pKa and solubility empirically for your lot and application.

Green Alternatives

Green-chemistry considerations are most relevant to solvent and process choices. For a small-molecule research compound with unknown solubility profile, you can reduce environmental impact by selecting greener dissolution and handling options where compatible with your workflow.

  • Preferred dissolution solvents (when feasible):
    • Water or buffered aqueous media with minimal DMSO carryover if the compound is sufficiently polar and stable.
    • Bio-based/greener organics for non-aqueous tasks: 2-methyltetrahydrofuran (2-MeTHF) or cyclopentyl methyl ether (CPME) instead of traditional ethers; ethyl acetate instead of chlorinated solvents.
  • Avoid where possible: Chlorinated solvents (e.g., dichloromethane, chloroform) and high-toxicity dipolar aprotics (e.g., NMP). If unavoidable, use at minimal scale in closed systems with proper waste segregation.
  • Energy minimization: Favor ambient-temperature dissolution with sonication over heating; store as concentrated stocks to reduce repeated solvent use.
  • Waste reduction: Aliquot stocks to extend shelf-life, preventing degraded/unused material disposal.

Comparison (general, not item-specific):

  • DMSO vs DMF: DMSO typically offers lower toxicity and better assay compatibility; DMF is less green and often unnecessary unless solubility demands it.
  • EtOAc vs DCM: Ethyl acetate provides comparable dissolving power for many organics with a better environmental profile.

All substitutions must be validated for your specific assay or analytical method, as performance and stability are compound-dependent.

Pharmaceutical Uses
  • Regulatory/formulation status: No pharmacopeial status or excipient role is provided. This product is offered strictly for research use only and is not manufactured under GMP for clinical use.

Context for researchers (general):

  • If TMP920 is being considered as a research tool compound in preformulation studies, determine its solid form (polymorph, solvate, salt) and perform basic developability screens (solubility, pKa, logD, stability) prior to any advanced work.
  • Do not incorporate into products for human or veterinary administration. For preclinical formulation research, employ appropriate controls and internal specifications; none are provided here for this SKU.
  • If a salt form is advantageous (improved solubility/stability), generate and characterize salts following standard screening protocols; note that the supplied form for this item is not specified and should be confirmed via CoA.

No therapeutic or clinical claims are made or implied.

Physical Properties

Item-specific physicochemical values have not been provided. Where a property is not listed, consult the CoA/Spec Sheet or characterize in-house.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable to solids; if liquid, not specified for this item; refer to CoA/Spec Sheet.

Practical characterization guidance (general):

  • Solubility screening (general): Evaluate DMSO at room temperature up to 50–100 mM; if insoluble, warm to 37–40 °C with sonication. If aqueous work is intended, perform cosolvent titrations (e.g., 0–5–10% DMSO in PBS) and note turbidity limits.
  • Ionization behavior (general): If basic or acidic functionalities are suspected, measure apparent pKa by UV titration or LC–MS pH profiling to inform buffer selection and plating stability.
  • Stability checks (general): Assess solution stability by LC–UV/LC–MS over 24–72 h at ambient light and temperature versus protected/4 °C conditions to determine handling windows.
  • Hygroscopicity/photolability: Not specified for this item; verify experimentally (gravimetric moisture uptake; light-exposure test) if critical for your assay.

All numerical values required for specification control should come from the item’s CoA/SDS.

Quality and Grades
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Guidance on interpreting grades for small-molecule research compounds (general):

  • Typical library/screening compounds are supplied at assay-ready purity (often ≥95% by HPLC/LC–MS). However, this is not specified for TMP920; confirm on the CoA for this lot/sku.
  • Purity metrics: Review the analytical method (e.g., HPLC vs. UPLC), wavelength(s) used, and detection mode (UV/ELSD/MS). For chromophore-poor compounds, ELSD or MS is informative.
  • Identity confirmation: CoA may include HRMS or MS; orthogonal NMR confirmation is recommended when SAR, reference standards, or regulatory submissions are planned.
  • Residual solvents/water: Not specified for this item; review CoA for Karl Fischer water and residual solvent profiles if sensitivity exists in your application.
  • Counter-ions/salt form: If a salt is provided, the CoA should list the form and assay as free base/acid. This item’s salt form is not specified; verify before use when dosing by molarity.
  • Stabilizers/additives: Not specified for this item; refer to CoA/Spec Sheet.

Recommendation: Before screening or quantitative studies, record lot-specific potency normalization by determining exact concentration with quantitative NMR or UV if the extinction coefficient is known (only if such data are available for your own reference standard).

Reaction and Applications

This catalog entry is positioned as a small-molecule research compound rather than a general-purpose reagent or solvent. Without structural information, specific synthetic reaction roles cannot be prescribed for TMP920.

Typical applications for cataloged screening compounds (general):

  • Assay development and method qualification: Use as a reference test article in biochemical, biophysical, or cell-based screens once you have verified identity/purity internally.
  • Analytical standards: Prepare calibration/qualifier solutions for LC–MS/LC–UV methods used to track exposure, stability, or metabolism in research settings.
  • SAR and tool compound work: If TMP920 corresponds to a known chemotype in your program, employ in parallel testing to benchmark new analogs.

Practical handling for assay use:

  • Prepare concentrated DMSO stocks (e.g., 10–50 mM) based on actual assay as free base/acid if applicable. Aliquot to minimize freeze–thaw.
  • Validate solubility at working concentration in your assay media; check for precipitation upon dilution by visual inspection and LC.
  • Track plate map, dispense history, and exposure time; many small molecules undergo DMSO- or light-mediated degradation.

Note: If you intend to use TMP920 as a synthetic building block or reaction partner, first obtain the structure and functional-group map and develop conditions accordingly; otherwise, such use is not recommended.

Reaction Conditions

No reaction conditions can be prescribed specifically for TMP920 without knowledge of its structure and functional groups.

General guidance for exploratory transformations on unknown or partially characterized small molecules:

  • Start with analytical-scale tests (1–10 mg) to identify sensitivity to acid/base, heat, and redox conditions.
  • For amide couplings (if a carboxylic acid or amine is present), begin with mild reagents (e.g., HATU/DIPEA in DMF/DCM or EDCI/NHS in DMF) and screen bases and solvents.
  • For cross-couplings (if aryl halides/boronates exist), use standard Pd catalysts (e.g., XPhos/Pd for Buchwald–Hartwig; SPhos/Pd for Suzuki) and test 25–80 °C in toluene/1,4-dioxane/Me-THF with aqueous base where suitable.
  • Maintain rigorous anhydrous/oxygen-free technique when indicated by the functional groups (e.g., air-sensitive heteroaryl boronates).
  • Continuously monitor by LC–MS to avoid overreaction and to map byproduct pathways; isolate and characterize intermediates to verify site-selectivity.

These are general literature practices and are not specific to this item; do not proceed without a confirmed structural map of TMP920.

Safety and Handling

Safety details specific to this item have not been provided in the product data. Always defer to the product SDS for authoritative guidance.

  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word / H-statements / Pictograms: Not specified for this item; refer to SDS.
  • Storage conditions: Store at −20 °C (per product data). Avoid repeated freeze–thaw by aliquoting. Allow vials to equilibrate to room temperature in a desiccator before opening to minimize condensation.
  • Incompatibilities: Not specified for this item. As general practice for small organic molecules, avoid strong oxidizers and strong acids/bases unless stability is known.
  • PPE (general): Lab coat, safety glasses, and appropriate chemical-resistant gloves (e.g., nitrile). Handle powders in a fume hood to minimize inhalation exposure.
  • First aid (general overview; consult SDS): In case of skin contact, wash with soap and water. For eye contact, rinse cautiously with water for several minutes. If inhaled, move to fresh air. If ingested, rinse mouth and seek medical attention.
  • Spill/cleanup (general): Avoid dust formation. Collect with inert absorbent, place in suitable container for disposal according to institutional and local regulations.
  • Waste: Dispose of as organic chemical waste in accordance with local regulations and your EHS policies.

Note: No medical or clinical use is implied; for research use only.

Solvent Selection

Because structural and solubility data are not specified, choose solvents via a tiered screening that works broadly for drug-like small molecules.

General solvent strategy:

  • Primary stock solvent: DMSO is the default for discovery compounds due to broad solvating power and assay compatibility up to 0.1–1% v/v in many biochemical and cell-based assays.
  • Secondary polar aprotics: DMF or DMA can dissolve challenging polar/heteroatom-rich scaffolds; subsequently dilute into aqueous buffers with small DMSO carryover.
  • Protic organics: Ethanol or isopropanol may be suitable where DMSO is undesirable; confirm assay tolerance.
  • Aqueous work: Use buffer with 0.5–5% DMSO or 0.1–1% nonionic surfactant (e.g., polysorbate) if precipitation is observed. Confirm stability and activity.
  • Nonpolar media: If lipophilicity is suspected, solubility may improve in ethyl acetate, 2-MeTHF, or toluene for non-aqueous workflows (e.g., material handling, crystallization), recognizing these are not cell-assay friendly.

Practical tips:

  • Heat (≤40 °C) and bath sonication can accelerate dissolution; avoid prolonged heating.
  • Filter 0.2 µm PTFE/nylon for particulate removal if compatible; verify no analyte adsorption.
  • Document final cosolvent percentage in assays to maintain reproducibility across plates and lots.

No item-specific partition data, dielectric constants, or solubility values are provided; consult the CoA/Spec Sheet and perform small-scale pretests.

Storage and Reconstitution

Item-specific storage and logistics:

  • Storage temperature: Store at −20 °C (per product data).
  • Shipping conditions: Shipped in an ice chest with ice pads (per product data).

General best practices for small-molecule solids and solutions:

  • Upon receipt: Inspect packaging temperature indicators if present. Allow the sealed container to reach room temperature before opening to prevent moisture condensation.
  • Solid storage: Keep tightly closed in a dry, inert atmosphere (desiccant recommended). Light protection is prudent for many organics; photosensitivity for this item is not specified.
  • Aliquoting: If frequent access is anticipated, subdivide into single-use aliquots to avoid repeated freeze–thaw and headspace moisture ingress.
  • Solution storage: Prepare concentrated DMSO or ethanol stocks where appropriate; store at −20 °C or −80 °C in sealed, low-bind vials. Avoid more than 2–3 freeze–thaw cycles. Actual solution stability and shelf-life are not specified for this item and should be established by LC–MS/HPLC.
  • Reconstitution solvent: Not specified for this item; DMSO is commonly used for discovery compounds. Confirm solubility empirically and adjust with gentle heat/sonication if needed.

Always refer to the CoA and SDS for lot-specific stability, purity, and handling information. Research use only.

Structure and Identity

Brief overview: This listing is for a cataloged small-molecule research compound sold under the name TMP920 (SKU T647858; CAS 1421837-45-7). Specific structural identifiers have not been provided for this item.

  • Product name: TMP920
  • SKU: T647858
  • CAS: 1421837-45-7
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • PubChem CID: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

  • Because a structure is not provided in the product data, users should verify identity by orthogonal analytical methods appropriate for small molecules (e.g., 1H/13C NMR, LC–MS, HRMS, HPLC purity, and, when needed, 2D NMR and elemental analysis).
  • If you have an internal or literature structure associated with CAS 1421837-45-7, confirm concordance by comparing NMR chemical shifts, exact mass, and retention behavior versus reference data.

2D structure description:

  • Not specified for this item; refer to CoA/Spec Sheet. If you possess the structure, document functional groups (e.g., heteroaromatics, amide/urea/ether motifs, halogens) and any stereocenters, as these inform solubility, ionization, and storage considerations.
Synthetic Utility

Specific synthetic roles cannot be defined because the structure and functional groups of TMP920 are not provided in the product data.

General considerations if you intend to derivatize or use as a building block:

  • Obtain and confirm the structure (including any stereochemistry) via supplier documentation or literature associated with CAS 1421837-45-7.
  • Map reactive handles (e.g., amines, acids, halides, heteroaromatics) and assess compatibility with common transformations (amide coupling, SNAr, cross-coupling, reductive amination, etc.).
  • Establish protecting-group strategy only after identifying acid/base and redox sensitivities; unknown stability profiles argue for mild conditions and small-scale scouting.
  • Verify purity by HPLC and identity by NMR/HRMS before and after each transformation; impurities in the starting material can confound SAR or yield assessments.

If the compound is intended solely as a screening tool rather than a synthon, using it unmodified under assay-validated conditions is recommended.

Target Specificity

No target, enzyme, receptor, or pathway specificity information is provided for TMP920 in the product data.

  • Antigen/epitope/clone/isotype fields are not applicable to small molecules.
  • If your internal records associate TMP920 (CAS 1421837-45-7) with a specific biological target, independently verify the structure and lot identity before interpreting any potency or selectivity metrics.

For authoritative target data, consult peer-reviewed literature or internal screening results; none are supplied here.

Foire aux questions

What is the purity of this product?
This product is supplied at ≥99% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 1421837-45-7, the molecular formula is C29H30N2O3, and the molecular weight is 454.56 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.